DE69230930T2 - Verfahren zur Herstellung von fusionierten Zellen - Google Patents

Verfahren zur Herstellung von fusionierten Zellen

Info

Publication number
DE69230930T2
DE69230930T2 DE69230930T DE69230930T DE69230930T2 DE 69230930 T2 DE69230930 T2 DE 69230930T2 DE 69230930 T DE69230930 T DE 69230930T DE 69230930 T DE69230930 T DE 69230930T DE 69230930 T2 DE69230930 T2 DE 69230930T2
Authority
DE
Germany
Prior art keywords
cell
medium
human
producing
proliferation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69230930T
Other languages
German (de)
English (en)
Other versions
DE69230930D1 (de
Inventor
Hideaki Hagiwara
Hideo Yuasa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69230930D1 publication Critical patent/DE69230930D1/de
Application granted granted Critical
Publication of DE69230930T2 publication Critical patent/DE69230930T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69230930T 1991-12-25 1992-12-24 Verfahren zur Herstellung von fusionierten Zellen Expired - Fee Related DE69230930T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3356551A JPH0763363B2 (ja) 1991-12-25 1991-12-25 融合細胞の取得方法

Publications (2)

Publication Number Publication Date
DE69230930D1 DE69230930D1 (de) 2000-05-25
DE69230930T2 true DE69230930T2 (de) 2000-08-17

Family

ID=18449596

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230930T Expired - Fee Related DE69230930T2 (de) 1991-12-25 1992-12-24 Verfahren zur Herstellung von fusionierten Zellen

Country Status (9)

Country Link
US (1) US5602027A (enExample)
EP (1) EP0552569B1 (enExample)
JP (1) JPH0763363B2 (enExample)
KR (1) KR100280241B1 (enExample)
AU (1) AU665594B2 (enExample)
DE (1) DE69230930T2 (enExample)
DK (1) DK0552569T3 (enExample)
IL (1) IL104157A (enExample)
TW (1) TW265364B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5251936A (en) * 1991-06-05 1993-10-12 Fitzgibbons Gary W Overlap check construction or similar business form
US5643745A (en) * 1994-02-03 1997-07-01 University Of Hawaii Heterologous dimeric proteins produced in heterokaryons
US5683899A (en) * 1994-02-03 1997-11-04 University Of Hawaii Methods and compositions for combinatorial-based discovery of new multimeric molecules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4594325A (en) * 1981-03-26 1986-06-10 The Regents Of The University Of Calif. High fusion frequency fusible lymphoblastoid cell line
JPS60141285A (ja) * 1983-12-29 1985-07-26 Hironori Murakami ヒトハイブリド−マ作成用親細胞株
US4757018A (en) * 1985-02-11 1988-07-12 Hazleton Biotechnologies, Inc. Myeloma cell lines and uses thereof
JP2599123B2 (ja) * 1985-12-28 1997-04-09 萩原 義秀 新規なヒトｂセル・リンパ芽球細胞変異株
EP0262211A1 (en) * 1986-04-01 1988-04-06 Genelabs, Incorporated Immortalized cells which produce tissue-specific products
IL87737A (en) * 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells

Also Published As

Publication number Publication date
EP0552569A1 (en) 1993-07-28
DK0552569T3 (da) 2000-07-17
JPH0763363B2 (ja) 1995-07-12
DE69230930D1 (de) 2000-05-25
US5602027A (en) 1997-02-11
AU3022992A (en) 1993-07-01
IL104157A (en) 1999-06-20
KR100280241B1 (ko) 2001-04-02
TW265364B (enExample) 1995-12-11
JPH05176763A (ja) 1993-07-20
IL104157A0 (en) 1993-05-13
EP0552569B1 (en) 2000-04-19
AU665594B2 (en) 1996-01-11
KR930013098A (ko) 1993-07-21

Similar Documents

Publication Publication Date Title
DE69518919T2 (de) Autoantikörper enthaltende zusammensetzung für tumorbehandlung und -vorbeugung
DE3301249C2 (enExample)
DE69110084T2 (de) In-vitro Verfahren zur Amplifikation von antigenspezifishe monoklonale Antikörper produzierenden menschlichen Lymphozyten des peripheren Blutes.
DE69427928T3 (de) Humane monoklonale anti-TNF alpha Antikörper
DE69509647T2 (de) Agonistische antikörper gegen den flk2/flt3-rezeptor und deren verwendungen
DE69128774T2 (de) GEREINIGTE IgG ANTIKÖRPER
DE69130702T2 (de) Geflügelspezifischen immunglobulin g produzierende hybridomas
DE3783277T2 (de) Monoklonaler antikoerper gegen humanes lungenkarzinom.
DE69132629T2 (de) Oberflächenkomplexbildung von lymphotoxin
EP0093436B1 (de) Verfahren zur Herstellung permanenter tierischer und humaner Zellinien und deren Verwendung
DE69510174T2 (de) Verfahren und Reagenz zur Bestimmung von menschlichen Störungen
DE3851571T2 (de) Krebsbezügliche antigenspezifische menschliche Immunoglobuline und menschliche-menschliche Hybridome, die diese menschlichen Immunoglobuline produzieren können.
DE69123121T2 (de) Synthetischer poly-ig-rezeptor, rezeptor-antikörper-komplexe, herstellung und anwendung
DE69227589T2 (de) Ecdysteroid-abhängige gen regulierung in säugetier-zellen
DE68921374T2 (de) Monoklonaler Antikörper gegen menschliche Mangan-Superoxiddismutase, Verfahren zu dessen Herstellung, Testreagens, Kit und Testmethode unter Verwendung desselben, Verfahren zur Diagnose von menschlichem Eierstockkrebs und von Herzinfarkt.
CH683526A5 (de) Zellinie für die Herstellung von Antikörper bildenden Hybridomen, Verfahren zur Herstellung einer menschlichen Zellinie und Antikörper produzierendes Hybridom.
DE69230930T2 (de) Verfahren zur Herstellung von fusionierten Zellen
DE69431531T2 (de) Immortalisierte menschliche fötale osteoblastenzellen
DE69331574T2 (de) Thymus-stammendes, immunverstärkendes agens zur therapeutischen verwendung in einem wirt mit einem angegriffenen immunsystem
DE3325131C2 (enExample)
DE68921282T2 (de) Verfahren zur Herstellung von Human-Human-Hybridomen, die Herstellung monoklonaler bzw. polyklonaler Antikörper davon und therapeutische Verwendung davon.
DE69011898T2 (de) Gegen menschlichen Papillomavirus monoklonaler Antikörper, Hybridom, das ihn produziert, und Verfahren zur Herstellung.
DE60021373T2 (de) Verfahren der zellkultivierung
DE3783511T2 (de) Verfahren zur zuechtung tierischer zellen und geeignete medien.
CH675727A5 (enExample)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee